SINOVAC BIOTECH LTD (SVA) Total liabilities 2016–2025
SINOVAC BIOTECH LTD (SVA) total liabilities at each fiscal year-end, per SEC filings.
$2.1BFY2025 · since FY2016: $81.7M → $2.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.1B | +5.0% |
| FY2024 | $2.0B | +3.8% |
| FY2023 | $2.0B | +10.2% |
| FY2022 | $1.8B | -44.2% |
| FY2021 | $3.2B | +310.3% |
| FY2020 | $781.2M | +680.4% |
| FY2019 | $100.1M | +28.6% |
| FY2018 | $77.9M | -36.2% |
| FY2017 | $122.1M | +49.4% |
| FY2016 | $81.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice